Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 87,895 | 81,505 | 72,257 | 64,829 | 66,831 |
| Cost of Goods | 1,436 | 1,451 | 1,377 | 1,240 | 1,579 |
| Gross Profit | 86,459 | 80,054 | 70,880 | 63,589 | 65,252 |
| Operating Expenses | 51,882 | 47,501 | 46,624 | 44,873 | 40,933 |
| Operating Income | 35,013 | 33,004 | 24,633 | 18,956 | 24,898 |
| Other Income | 1,447 | 1,348 | 1,178 | 1,097 | 1,042 |
| Pre-tax Income | 36,460 | 34,352 | 25,811 | 20,053 | 25,940 |
| Income Tax | 7,079 | 8,012 | 5,625 | 1,779 | 3,932 |
| Net Income Continuous | 29,381 | 26,340 | 20,186 | 18,274 | 22,008 |
| Net Income | $29,381 | $26,340 | $20,186 | $18,274 | $22,008 |
| EPS Basic Total Ops | 0.25 | 0.23 | 0.18 | 0.16 | 0.19 |
| EPS Basic Continuous Ops | 0.26 | 0.23 | 0.18 | 0.16 | 0.19 |
| EPS Diluted Total Ops | 0.23 | 0.22 | 0.17 | 0.15 | 0.18 |
| EPS Diluted Continuous Ops | 0.24 | 0.22 | 0.17 | 0.15 | 0.18 |
| EBITDA(a) | $35,574 | $33,579 | $25,159 | $19,465 | $23,250 |